Bactolife raised €30M in a Series B round announced on January 8, 2026. Bactolife empowers worldwide health through a fortified gut microbiome.
Bactolife empowers worldwide health through a fortified gut microbiome.
Bactolife, based in Copenhagen, Denmark, announced €30M in Series B financing on January 8, 2026.
Participants include Novo Holdings, EIFO, Athos Capital, Cross Border Impact Ventures.
Oviva provides personalized dietary advice combined with digital tools to help individuals change their habits and improve their health.
German deeptech firm Orbem is using AI-powered MRI technology to scan biological samples in food, construction and medical environments.
Orbital develops AI technology tailored to the specific requirements of real estate legal work, an area that has seen relatively limited coverage from broader legal technology platforms.